# Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial

> **NCT05378113** · PHASE2 · TERMINATED · sponsor: **Emory University** · enrollment: 6 (actual)

## Conditions studied

- Injection Site Irritation

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT05378113
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-18
- **Primary completion:** 2023-08-03
- **Final completion:** 2023-08-03
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study was terminated due to enrollment challenges following the relocation of orthopedic procedures to a different hospital.
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05378113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05378113, "Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05378113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*